CPC Biotech launches Quattroflow HTX pump drive with touchscreen and fluid-specific calibration.

CPC Biotech, part of Dover Corporation, introduced the Quattroflow HTX, a new pump drive designed for biopharmaceutical processing. It features a user-friendly five-inch touchscreen, flexible remote operation, and fluid-specific calibration for precise flow control. The HTX supports both single-use and multiple-use pump heads, offers enhanced motor and software capabilities, and is suitable for applications like media transfer, dispensing, and filtration. This launch represents the next generation of their HT platform, aiming to improve accuracy and ease of use in bioprocessing environments.

Dover Corporation (DOV) trades at USD 212.23 on Pluang, showing a slight gain of 0.11% as of Nov 12, 2026, 04:22 WIB. The company holds a market cap of $28.20 billion and a dividend yield of 0.99%. This stable performance coincides with CPC Biotech's launch of the Quattroflow HTX pump drive, part of Dover, which aims to advance bioprocessing technology.